Pharma Bio Category

Showing 151–180 of 429 results

  • Venture

    G+FLAS Life Sciences

    CRISPR/Cas genome editing

  • Global

    Galderma Korea., Ltd.

    Pharmaceuticals

  • Large

    GC Cell

    GC Cell is a company in cell and gene therapy innovation, offering a holistic approach that encompass everything from research and development to bring products to market. They carry out integrated R&D under the goal of commercialization of cell therapy products, from fundamental research to GMP production and product analysis for clinical studies.

  • Venture

    Gencellmed

    GenCellMed is a company that was established as a result of the merger between ‘GenCellMed’, a liquid biopsy company, and ‘ZeroMix’, a genome analysis company. They are currently focusing on the commercialization of the ADC platform business.

  • Diagnostics

    GENCURIX

    Prospective, randomized, comparative study

  • Venture

    GeneKore

  • Diagnostics

    Genematrix Inc.

    Molecular diagnostics

  • Venture

    GeneMedicine

    GeneMedicine(GM) is a clinical stage biopharmaceutical company focused on developing next-generation viral immunotherapies, aiming to transform the therapeutic outcomes for cancer patients.

  • SME

    GeneOne Life Science

    Nucleic-acid based treatments and novel small-molecule therapeutics

  • Venture

    Generoath

    Generoath is a company that develops drugs for treating neurological diseases. Their pipeline includes products like GO-101, GO-102, GO-201, GO-301, GO-401 for diseases such as Parkinson’s disease, amyotrophic lateral sclerosis, retinal degenerative disease, epilepsy, and companion biomarker.

  • Equipment

    Genewel Inc.

    Information not readily available

  • SME

    Genexine, Inc.

    Biosimilars, small molecules, and bispecific mAbs

  • SME

    GENOFOCUS

    GenoFocus is a company that develops special enzymes and microbiome therapeutics. They have developed a range of products including industrial special enzymes such as lactase, catalase, and proteinase K.

  • Placeholder
    Diagnostics

    Genomaine Co., Ltd.

    Information not readily available

  • Venture

    Genome & Company

    Genome & Company is a pharmaceutical bio company that focuses on the research and development of immune anti-cancer drugs and new target microbiome drugs.

  • Diagnostics

    Genomictree

    In Vitro Diagnostics markets

  • Venture

    GI BIOME

    GI BIOME is a company that focuses on the research and development of microbiome therapeutics. They are involved in various areas including the mucosal immune system and microbiome.

  • Venture

    GI Cell

    GI Cell is focused on developing innovative and competitive cell therapies. They aim to provide safe, effective, and superior immune cell therapies with cutting-edge technology.

  • Venture

    GI Innovation

    GI Innovation is a biopharmaceutical company that aims to develop innovative biologics to cure diseases. They are working on various projects based on their 3S strategy: Science, Strategy, and Speed. They aim to create a synergy in new drug development through solid intermediary research and strategic collaboration with global pharmaceutical companies.

  • SME

    GL Pharm Tech

    Information not readily available

  • SME

    GL Pharma

    Drug development

  • Global

    GlaxoSmithKline Korea

    Pharmaceuticals

  • Venture

    GoodTCells

    Good T Cells is developing First-In-Class immunotherapeutics and diagnostic reagents against cancer and autoimmune diseases.

  • Ingredient

    Green Pharm. Co., Ltd.

    Health Functional Food and Food

  • SME

    Guju Pharm. Co., Ltd

    Pharmaceuticals

  • SME

    HAMSOA

    Drug development

  • Large

    Han Kook Shin Yak Pharm. Co., Ltd.

    Pharmaceuticals

  • SME

    Hana Pharm. Co. Ltd.

    Pharmaceuticals

Scroll to Top